A clinical study for FS-311(hemodiafilter)

Not Applicable

Completed

• Conditions: Renal failure

• Registration Number: JPRN-UMIN000018858
• Lead Sponsor: Toray Industries,Inc.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-09-01
• Study Completion: 2015-09-22
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 14

Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who are pregnant or suspected to be pregnant, patients who are breast-feeding 2)Patients who are judged to be unable to attend this study as cardiovascular diseases by the investigator 3)Patients who have severe anemias or severe cardiovascular complications, patients who have severe arteriosclerosis obliterans 4)Patients with a history of allergy against extracorporeal circulation therapy 5)Other patients who are considerd ineligible for this study by the investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1)adverse events 2)Device deficiencies 3)blood compatibility(change of a white blood-cell count and platelets count during the HDF session)